Gradiant’s Chief Technology Officer Prakash Govindan spoke to Global Water Intelligence Magazine about Gradiant’s research development, geographic expansion, and the future of water treatment. Read the full interview at the link below!
Aramis Biosciences Announces FDA Clearance of IND Application for A197, a Novel Immunomodulatory Agent for the Treatment of Dry Eye Disease
BOSTON, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Aramis Biosciences, Inc., a clinical-stage immuno-ophthalmology biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for A197...